[Federal Register: March 17, 2005 (Volume 70, Number 51)]
[Notices]
[Page 13032-13033]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17mr05-58]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Cooperative Agreement With the Kenya Medical Research Institute
(KEMRI); Notice of Intent To Fund Single Eligibility Award
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
intent to fund fiscal year (FY) 2005 funds for a cooperative agreement
program to:
1. To conduct field and laboratory research and implement public
health programs on important human infectious diseases, with an
emphasis on HIV/AIDS, malaria, emerging and other emerging and re-
emerging infectious diseases as well as other identifiable public
health problems.
2. To provide training for students and public health professionals
in basic and applied public health research, public health program
planning, implementation and evaluation and other related issues such
as data collection, financial planning and management.
3. To strengthen the Kenya Medical Research Institute KEMRI)
institutional capacity to conduct research, plan, implement and
evaluate public health programs, provide surveillance, and develop
interventions as well as support national and regional infectious
disease identification and control efforts.
4. To incorporate the results of research into operational disease
prevention and control programs in the Republic of Kenya and ensure
sharing of expertise and research findings with other nations.
The Catalog of Federal Domestic Assistance number for this program
is 93.283.
B. Eligible Applicant
Assistance will be provided only to KEMRI. No other applications
are solicited. KEMRI is the most appropriate and qualified agency to
conduct the activities specified under this cooperative agreement
because:
1. KEMRI is the only research organization in Kenya that possesses
the requisite scientific and technical expertise, the infrastructure
capacity and who has conducted malaria and
[[Page 13033]]
HIV research in areas of high morbidity (20 years for malaria and 10
years for HIV/AIDS). These combined attributes make them uniquely
qualified as the only organization in Kenya capable of effectively
conducting the research and public health program activities proposed
for this cooperative agreement.
2. A major operational unit of KEMRI is located in an area of
western Kenya with intense and perennial malaria transmission and where
incidence and prevalence is very high, and thus is ideally located to
evaluate approaches to preventing and controlling these public health
problems.
3. KEMRI was established through the Science and Technology Act of
the Republic of Kenya and has a Board of Management appointed by the
Minister of Health which is responsible for overseeing all research and
which has a well-developed secretariat to provide administrative and
technical support to research services.
4. KEMRI has been collaborating with health agencies on priority
infectious disease research for over 20 years on the grounds of KEMRI
facilities in Nairobi, Kisumu and other locations in Kenya. KEMRI has
experienced staff, equipment, and facilities to support the
collaboration.
C. Funding
Approximately $5,000,000 is available in FY 2005 to fund this
award. It is expected that the award will begin on or before August 15,
2005, and will be made for a 12-month budget period within a project
period of up to five years. Funding estimates may change.
D. Where To Obtain Additional Information
For general comments or questions about this announcement, contact:
Technical Information Management, CDC Procurement and Grants Office,
2920 Brandywine Road, Atlanta, GA 30341-4146. Telephone: 770-488-2700.
For program issues, contact: Ron Stoddard, Division of Parasitic
Diseases, 4770 Buford Highway, Atlanta, GA 30341. Telephone: (770) 488-
7707. E-mail: RStoddard@cdc.gov.
Dated: March 11, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 05-5287 Filed 3-16-05; 8:45 am]
BILLING CODE 4163-18-P